全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

MHC Disparate Resting B Cells Are Tolerogenic in the Absence of Alloantigen-Expressing Dendritic Cells

DOI: 10.5402/2013/701051

Full-Text   Cite this paper   Add to My Lib

Abstract:

Resting B cell (rB) populations have been shown to tolerize to soluble proteins and to minor-H but not to MHC alloantigens. We speculated that the reason for failing to tolerize to MHC alloantigen is that the few remaining dendritic cells (DCs) contaminating purified rB cell populations efficiently activate MHC allospecific T cells which are present at a higher frequency than T cells specific for minor-H alloantigen and soluble proteins. We established that MHC disparate rB cells are indeed tolerogenic when devoid of DC populations, as parental strain mice showed delayed skin graft rejection when infused with rB cells from mice in which MHC class I alloantigen was specifically targeted to T and B cells (CD2- transgenic mice). In contrast, treatment of parental strain mice with allogeneic rB cells purified from MHC- transgenic mice, in which is ubiquitously expressed, including DCs, induced accelerated graft rejection. We also showed that adding only 5,000 expressing DCs to CD2- rB cells abrogated the tolerogenic effect. Surprisingly, allogeneic rB cells prolonged graft survival in -primed mice. Thus, MHC disparate rB cells are tolerogenic and their failure to delay graft rejection can be explained by contaminating allogeneic DCs. 1. Introduction Resting B cells have been suggested to be potent inducers of specific unresponsiveness both in vitro and in vivo [1, 2] and have been thought to mediate such effects by directly presenting Ag (signal 1) in the absence of productive costimulatory interactions, principally mediated by B7-CD28 and CD40-CD40L interactions (signal 2) [3–6]. This hypothesis, however, has been challenged by studies demonstrating that rB cells not only express CD40, but also upregulate expression of B7 family members in a timely fashion in vivo [7]. Moreover, it has become increasingly appreciated that indirect antigen presentation, in which antigen shed from donor cells is presented via immature host DC, may be crucial for tolerance induction [8–11]. Regardless of the mechanism, rB cells clearly have tolerogenic effects on T cells specific for some types of antigen, but not others. For instance, rB cells induce tolerance to soluble proteins [2, 12] and to minor-H mismatched transplants [1], but not to transplants discrepant in MHC alloantigens [7]. That MHC disparate grafts present a higher bar for tolerance induction in general is emphasized by studies showing that MHC-expressing allografts are rejected even in the absence of the “danger” signals that appear requisite in generation of immune responses to other antigens, presumably by

References

[1]  E. J. Fuchs and P. Matzinger, “B cells turn off virgin but not memory T cells,” Science, vol. 258, no. 5085, pp. 1156–1159, 1992.
[2]  E. E. Eynon and D. C. Parker, “Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens,” Journal of Experimental Medicine, vol. 175, no. 1, pp. 131–138, 1992.
[3]  I. S. Grewal and R. A. Flavell, “A central role of CD40 ligand in the regulation of CD4+ T-cell responses,” Immunology Today, vol. 17, no. 9, pp. 410–414, 1996.
[4]  C. A. Chambers and J. P. Allison, “Co-stimulation in T cell responses,” Current Opinion in Immunology, vol. 9, pp. 396–404, 1997.
[5]  D. J. Lenschow, T. L. Walunas, and J. A. Bluestone, “CD28/B7 system of T cell costimulation,” Annual Review of Immunology, vol. 14, pp. 233–258, 1996.
[6]  D. M. Harlan and A. D. Kirk, “The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?” Journal of the American Medical Association, vol. 282, no. 11, pp. 1076–1082, 1999.
[7]  M. Niimi, D. L. Roelen, W. Wong, M. Hara, P. J. Morris, and K. J. Wood, “Resting B cells as tolerogens in vivo but only for minor histocompatibility antigens: evidence for activation of resting B cells in vivo,” Transplantation, vol. 64, no. 9, pp. 1330–1335, 1997.
[8]  I. C. Rulifson, G. L. Szot, E. Palmer, and J. A. Bluestone, “Inability to induce tolerance through direct antigen presentation,” American Journal of Transplantation, vol. 2, no. 6, pp. 510–519, 2002.
[9]  S. P. Cobbold, K. F. Nolan, L. Graca et al., “Regulatory T cells and dendritic cells in transplantation tolerance: molecular markers and mechanisms,” Immunological Reviews, vol. 196, pp. 109–124, 2003.
[10]  S. A. Quezada, B. Fuller, L. Z. Jarvinen et al., “Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation,” Blood, vol. 102, no. 5, pp. 1920–1926, 2003.
[11]  A. E. Morelli, A. T. Larregina, W. J. Shufesky et al., “Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells,” Blood, vol. 104, no. 10, pp. 3257–3266, 2004.
[12]  S. R. M. Bennett, F. R. Carbone, T. Toy, J. F. A. P. Miller, and W. R. Heath, “B cells directly tolerize CD8+ T cells,” Journal of Experimental Medicine, vol. 188, no. 11, pp. 1977–1983, 1998.
[13]  A. W. Bingaman, J. Ha, S. Y. Waitze et al., “Vigorous allograft rejection in the absence of danger,” Journal of Immunology, vol. 164, no. 6, pp. 3065–3071, 2000.
[14]  S. A. Hansal, D. I. Morris, J. M. G. Sechler, P. E. Love, and A. S. Rosenberg, “Cutting edge: Induction of antigen-specific hyporesponsiveness by transplantation of hemopoietic cells containing an MHC class I transgene regulated by a lymphocyte-specific promoter,” Journal of Immunology, vol. 161, no. 3, pp. 1063–1068, 1998.
[15]  Y. Wang, D. Gao, K. E. Lunsford, W. L. Frankel, and G. L. Bumgardner, “Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection,” American Journal of Transplantation, vol. 3, no. 10, pp. 1251–1258, 2003.
[16]  K. Tsuji, Y. Obata, T. Takahashi, J. Arata, and E. Nakayama, “Requirement of CD4 T cells for skin graft rejection against thymus leukemia (TL) antigen and multiple epitopes on the TL molecule recognized by CD4 T cells,” Journal of Immunology, vol. 159, no. 1, pp. 159–166, 1997.
[17]  A. S. Rosenberg and A. Singer, “Cellular basis of skin allograft rejection: an in vivo model of immune-mediated tissue destruction,” Annual Review of Immunology, vol. 10, pp. 333–358, 1992.
[18]  H. I. McFarland, M. Puig, L. T. Grajkowska et al., “Regulatory T cells in γ irradiation-induced immune suppression,” PLoS ONE, vol. 7, no. 6, Article ID e39092, 2012.
[19]  D. Hawiger, K. Inaba, Y. Dorsett et al., “Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 769–779, 2001.
[20]  J. Bagley, C. Tian, D. H. Sachs, and J. Lacomini, “Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy,” Blood, vol. 99, no. 12, pp. 4394–4399, 2002.
[21]  D. J. Morgan, H. T. C. Kreuwel, and L. A. Sherman, “Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens,” Journal of Immunology, vol. 163, no. 2, pp. 723–727, 1999.
[22]  G. R. Otten and R. N. Germain, “Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production,” Science, vol. 251, no. 4998, pp. 1228–1231, 1991.
[23]  P. H?llsberg, V. Batra, A. Dressel, and D. A. Hafler, “Induction of anergy in CD8 T cells by B cell presentation of antigen,” Journal of Immunology, vol. 157, no. 12, pp. 5269–5276, 1996.
[24]  M. T. Crowley, K. Inaba, M. D. Witmer-Pack, S. Gezelter, and R. M. Steinman, “Use of the fluorescence activated cell sorter to enrich dendritic cells from mouse spleen,” Journal of Immunological Methods, vol. 133, no. 1, pp. 55–66, 1990.
[25]  A. M. Kruisbeek, “Isolation and fractionation of mononuclear cell populations,” in Current Protocols in Immunolgy, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds., John Wiley & Sons, New York, NY, USA, 1994.
[26]  T. J. Goldschmidt, R. Holmdahl, and L. Klareskog, “Depletion of murine T cells by in vivo monoclonal antibody treatment is enhanced by adding an autologous anti-rat κ chain antibody,” Journal of Immunological Methods, vol. 111, no. 2, pp. 219–226, 1988.
[27]  H. I. McFarland and A. S. Rosenberg, “Skin allograft rejection,” in Current Protocols in Immunology, J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds., Unit 4. 4, John Wiley & Sons, New York, NY, USA, 1994.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413